Alendronic Acid

DRUG2 trials

Sponsors

Odense University Hospital, University of Edinburgh

Conditions

Calcific Aortic Stenosisosteoporosis

Phase 2

Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.

CompletedNCT02132026

University of EdinburghCalcific Aortic Stenosis

Start: 2014-11-12End: 2019-11-28Updated: 2021-10-14

Phase 4

THE ALENDRONATE DISCONTINUATION STUDY

RecruitingCTIS2023-510042-24-01

Odense University Hospitalosteoporosis

Start: 2025-01-30Target: 1400Updated: 2025-08-08

Related Papers

Artificial Intelligence-Enabled Echocardiography as a Surrogate for Multimodality Aortic Stenosis Imaging: Post Hoc Analysis of a Clinical Trial.

2025-12-31

Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial

Heart2025-03-061 citations

Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial

Journal of the American Heart Association2024-09-096 citations

Thoracic Aortic 18F-Sodium Fluoride Activity and Ischemic Stroke in Patients With Established Cardiovascular Disease

JACC. Cardiovascular imaging2022-02-1638 citations

Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial

Circulation2021-04-29136 citations

Computed Tomography Aortic Valve Calcium Scoring in Patients With Aortic Stenosis

Circulation Cardiovascular Imaging2018-03-01360 citations

Optimization and Reproducibility of Aortic Valve 18F-Fluoride Positron Emission Tomography in Patients With Aortic Stenosis

Circulation Cardiovascular Imaging2016-10-0171 citations